Enliven Therapeutics
$43.16
961
+$4.22+10.84% Today
Statistics
Day High
43.28
Day Low
38.76
52W High
43.28
52W Low
13.3
Volume
3,033,972
Avg. Volume
1,339,096
Mkt Cap
2.56B
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
20MayExpected
Expected EPS
-0.461243
Actual EPS
N/A
Financials
-Profit Margin
Unprofitable0Revenue
-178.05MNet Income
Analyst Ratings
$50.50Average Price Target
The highest estimate is 56.00.
From 2 ratings within the last 6 months. This is not an investment recommendation.
From 2 ratings within the last 6 months. This is not an investment recommendation.
Buy 100%
Hold 0%
Sell 0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow ELVN. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
Merck
MRK
Mkt Cap298.84B
Bristol-Myers Squibb
BMY
Mkt Cap121.69B
Pfizer
PFE
Mkt Cap161.09B
Astrazeneca
AZN
Mkt Cap315.47B
Novartis
NVS
Mkt Cap297.32B
Roche
RHHBY
Mkt Cap321.08B
Gilead Sciences
GILD
Mkt Cap173.41B
AMGEN
AMGN
Mkt Cap187.56B
Regeneron Pharmaceuticals
REGN
Mkt Cap80.54B
Regions
About
Enliven Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of small molecule inhibitors to help patients with cancer. Its pipeline of small molecule kinase inhibitors include ELVN-001, which is being evaluated in a Phase 1 clinical trial in adults with chronic myeloid leukemia; and ELVN-002, a Phase 1 clinical trial has been activated to evaluate people with cancers harboring an abnormal HER2 gene. The company is based in Boulder, Colorado.
Show more...
CEO
Mr. Samuel S. Kintz M.B.A.
Employees
62
Country
US
ISIN
US29337E1029
Listings
0 Comments
Share your thoughts
FAQ
What is Enliven Therapeutics stock price today?▼
The current price of ELVN is $43.16 USD — it has increased by +10.84% in the past 24 hours. Watch Enliven Therapeutics stock price performance more closely on the chart.
What is Enliven Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Enliven Therapeutics stocks are traded under the ticker ELVN.
Is Enliven Therapeutics stock price growing?▼
ELVN stock has risen by +10.1% compared to the previous week, the month change is a +46.6% rise, over the last year Enliven Therapeutics has showed a +141.52% increase.
What is Enliven Therapeutics market cap?▼
Today Enliven Therapeutics has the market capitalization of 2.56B
When is the next Enliven Therapeutics earnings date?▼
Enliven Therapeutics is going to release the next earnings report on May 20, 2026.
What were Enliven Therapeutics earnings last quarter?▼
ELVN earnings for the last quarter are -0.48 USD per share, whereas the estimation was -0.39 USD resulting in a -24.68% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Enliven Therapeutics revenue for the last year?▼
Enliven Therapeutics revenue for the last year amounts to 0 USD.
What is Enliven Therapeutics net income for the last year?▼
ELVN net income for the last year is -178.05M USD.
How many employees does Enliven Therapeutics have?▼
As of April 07, 2026, the company has 62 employees.
In which sector is Enliven Therapeutics located?▼
Enliven Therapeutics operates in the Health Care sector.
When did Enliven Therapeutics complete a stock split?▼
The last stock split for Enliven Therapeutics was on February 24, 2023 with a ratio of 1:4.
Where is Enliven Therapeutics headquartered?▼
Enliven Therapeutics is headquartered in Boulder, US.